Phaarmasia sets Sept 25 AGM; approves FY26 profit of ₹1,757.3 lakh
- Phaarmasia schedules 45th AGM for September 25, 2026, via VC/OAVM with e-voting enabled.
- FY26 net profit turned positive at ₹1,757.28 lakh vs loss of ₹158.94 lakh in FY25.
- Revenue from operations grew 93.7% YoY to ₹4,720.75 lakh.
- Shareholders to approve ₹100 crore limit for related party transactions for FY27.
- Remuneration hike for Whole-time Director to ₹38.5 lakh per annum proposed.

*this image is generated using AI for illustrative purposes only.
Phaarmasia Limited has scheduled its 45th Annual General Meeting (AGM) for Friday, September 25, 2026, at 4:00 pm. The meeting will be conducted through Video Conferencing and Other Audio Visual Means (VC & OAVM). The company is enabling remote e-voting for shareholders from September 22 to September 24, 2026.
The primary agenda includes adopting the audited financial statements for FY26, which reported a net profit of ₹1,757.28 lakh, a significant turnaround from a net loss of ₹158.94 lakh in the previous year. Revenue from operations nearly doubled to ₹4,720.75 lakh from ₹2,436.88 lakh.
Key Resolutions
Shareholders will vote on several special business items:
- Related Party Transactions: Approval for transactions with related parties, including Maneesh Pharmaceuticals Limited and Svizera Health Private Limited, up to an aggregate value of ₹100 crore for FY27.
- Director Remuneration: Increase in the remuneration of Whole-time Director Mr. Naga Bhaskara Rao Yallapragada to ₹38.5 lakh per annum.
- Reappointment: Reappointment of Mrs. Rashmi Vinay Sapte as a director upon retirement by rotation.
Financial Highlights
| Metric | FY26 | FY25 | Change |
|---|---|---|---|
| Revenue from Operations | ₹4,720.75 lakh | ₹2,436.88 lakh | +93.7% |
| Net Profit After Tax | ₹1,757.28 lakh | (₹158.94 lakh) | Turnaround |
| Profit Before Tax | ₹2,138.78 lakh | (₹160.27 lakh) | Turnaround |
The substantial profit increase was driven largely by an exceptional item: a ₹1,898.70 lakh profit on the sale of land and building. Excluding this one-time gain, the operational profit before tax stood at ₹240.09 lakh, compared to an operational loss of ₹160.27 lakh in FY25.
What the Numbers Show
While the headline net profit reflects a strong turnaround, it is heavily influenced by non-operational gains. The ₹1,898.70 lakh exceptional gain constitutes approximately 88% of the total pre-tax profit. Operational revenue growth of 93.7% indicates improved business activity, but core profitability remains modest relative to the top-line expansion.
Voting Eligibility and Resources
Shareholders holding shares as of the cut-off date, Friday, September 18, 2026, are eligible to vote. The notice for the 45th AGM and the printed Annual Report for FY26 have been uploaded to the company’s website. Urvashi Bhatia, Company Secretary and Compliance Officer, issued the intimation to BSE Limited.
Historical Stock Returns for Phaarmasia
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -4.98% | +4.13% | -3.21% | +4.29% | +177.85% | +195.86% |
How will the approval of up to ₹100 crore in related party transactions with Maneesh Pharmaceuticals and Svizera Health impact Phaarmasia's operational independence and future revenue streams?
Given that 88% of pre-tax profit came from a one-time asset sale, what specific strategic initiatives are in place to sustain core operational profitability beyond FY26?
Will the proposed remuneration increase for the Whole-time Director align with performance metrics tied to organic revenue growth rather than exceptional gains?


































